CVU mini – Friday 21 June 2024 (postponed)
Due to overlap and parallels with other upcoming RSV events, we are postponing RSV presentations until our October CVU and will no longer be holding a separate CVU mini on 21 June 2024.
MVEC’s CVU mini was planned to be on the topic of RSV preventative therapies, offering healthcare professionals the opportunity to hear from leading experts on the latest in RSV prevention.
For regular updates from MVEC, 订阅我们的新闻 或关注我们@mvecau Instagram的 和 推特 以及墨尔本疫苗教育中心 – MVEC Facebook.
| June 2024 CVU mini program | |
| 9:00 am–9:25 am | 登记 |
| 9:25 am–9:30 am | Acknowledgement of country and welcome Ms Rachael McGuire |
| 9:30 am–10:15 am | RSV preventative therapies for infants and children Presented by Prof Nigel Crawford |
| 10:15 am–10:45 am | RSV vaccines for adults Presented by Dr Julia Marshall |
| 10:45 am–11:15 am | Safety of RSV preventative therapies Presented by Dr Ingrid Laemmle-Ruff |
| 11:15 am–11:45 am | 早茶 |
| 11:45 am-12:30 pm | Q&A Moderated by Ms Rachael McGuire |
Ms Rachael McGuire
教育护士协调员，MVEC
Rachael is a Registered Nurse and accredited Nurse Immuniser with a Graduate Certificate in Clinical Education. She has experience immunising at local council, travel clinics and hospital immunisation services, including SAEFVIC. Her special interests lie in vaccine safety, the immunisation of special risk groups and vaccine equity. In 2023, Rachael’s enthusiasm for public health led to her involvement in DFAT-funded projects in Lao PDR, providing education and support to improve decision-making around immunisation policy.
Prof Nigel Crawford
Director, MVEC, Murdoch Children’s Research Institute
Nigel 是澳大利亚墨尔本皇家儿童医院的儿科医生顾问和免疫服务负责人。他在卡迪夫大学获得公共卫生硕士学位（2006 年），在墨尔本大学获得疫苗学博士学位（2011 年）。他也是董事 赛维克，位于默多克儿童研究所的维多利亚疫苗安全服务机构（MCRI) 并帮助建立了 墨尔本疫苗教育中心 (MVEC). Nigel is a Professor at the Department of Paediatrics, University of Melbourne and his research interests include vaccine safety, immunisation of special risk groups and emerging infections, particularly those that may soon be vaccine preventable. He has been a member of the Australian Technical Advisory Group on Immunisation (安泰) since 2014 and became Chair in 2021.
Dr Julia Marshall
Human Infection Challenge Trial Consultant, The Peter Doherty Institute
Julia is A General Practitioner and Public Health Registrar and works as a Clinician-Scientist at The Peter Doherty Institute in vaccine development. For her PhD Julia developed the first controlled human infection model of aerosol BCG to aid in tuberculosis vaccine development and the world’s first SARS-CoV-2 human re-infection challenge model. She is a member of ATAGI.
Dr Ingrid Laemmle-Ruff
Immunisation Consultant, SAEFVIC, Murdoch Children’s Research Institute
Dr Ingrid Laemmle-Ruff is a general paediatrician and public health physician. She works in vaccine safety at SAEFVIC and in community paediatrics. She has interests in immunisation, immigrant health and child public health.
For regular updates from MVEC, 订阅我们的新闻 或关注我们@mvecau Instagram的 和 推特 以及墨尔本疫苗教育中心 – MVEC Facebook.
MVEC is proud to be affiliated with the following partners as part of the CVU mini.
